•
Dec 31, 2022

Bruker Q4 2022 Earnings Report

Bruker reported Q4 2022 financial results, with revenue increasing by 3.6% year-over-year and organic revenue growth of 8.9%.

Key Takeaways

Bruker's Q4 2022 results showed revenue growth, driven by strong organic performance. The company reported an increase in both GAAP and non-GAAP EPS, with non-GAAP EPS growing significantly. The company is guiding for continued revenue and EPS growth in FY 2023.

Q4 2022 revenues reached $708.4 million, a 3.6% increase year-over-year, with organic revenue growth of 8.9%.

GAAP EPS for Q4 2022 was $0.66, while non-GAAP EPS was $0.74, up 25.4% year-over-year.

Bruker Scientific Instruments (BSI) revenues increased by 3.6% year-over-year, with organic revenue growth of 8.5%.

Bruker Energy & Supercon Technologies (BEST) revenues increased by 1.9% year-over-year, with organic revenue growth of 13.6%.

Total Revenue
$708M
Previous year: $684M
+3.6%
EPS
$0.74
Previous year: $0.59
+25.4%
Organic Revenue Growth
8.9%
Previous year: 11.4%
-21.9%
Non-GAAP Operating Margin
21%
Previous year: 21%
+0.0%
Gross Profit
$366M
Previous year: $342M
+7.1%
Cash and Equivalents
$646M
Previous year: $1.07B
-39.6%
Free Cash Flow
$137M
Previous year: $110M
+24.2%
Total Assets
$3.62B
Previous year: $3.65B
-0.9%

Bruker

Bruker

Forward Guidance

Bruker expects FY 2023 revenue of $2.81 to $2.86 billion, representing 11% to 13% year-over-year reported revenue growth, including organic revenue growth of 8% to 10%. They anticipate FY 2023 non-GAAP EPS of $2.52 to $2.57, or 8% to 10% year-over-year non-GAAP EPS growth.

Positive Outlook

  • Organic revenue growth of 8% to 10%.
  • M&A contributions of approximately 1.5%.
  • Foreign currency translation tailwind of approximately 1.5%.
  • FY 2023 R&D expenses of approximately 10% of revenue.
  • FY 2023 non-GAAP EPS of $2.52 to $2.57, or 8% to 10% year-over-year non-GAAP EPS growth.